Forum Press Releases

DEC-18-12  Outdated terminology has made it difficult to assess the clinical benefits of next-generation direct-acting antiviral drugs and combination therapies now in the pipeline. A new paper from the Forum for Collaborative HIV Research recommends the adoption of a standardized nomenclature that will bring simplicity and clarity to the field, allow for inter-trial comparisons and can be adapted to continuing advances in hepatitis C virus (HCV) drug development.

NOV-21-12  At a time when the prevalence of HIV among some Americans rivals parts of sub-Saharan Africa and recorded deaths from chronic hepatitis C infection are steadily increasing, the Forum for Collaborative HIV Research will convene its 2012 National Summit on HIV and Viral Hepatitis Diagnosis, Prevention and Access to Care to intensify the nation's prevention, detection and treatment efforts.

AUG-15-12  As global leaders assembled in Washington for the XIX International AIDS Conference, a special gathering of researchers, government officials and HIV/AIDS advocates confronted the new reality of the epidemic in the U.S. – a dramatic increase in HIV among men who have sex with men (MSM), minority populations, the poor and the disenfranchised living in discreet geographic regions, especially in urban areas of the Northeast and West Coast and cities and small towns in the South.

MAY-31-12  Meeting in San Francisco at a conference convened by the Forum for Collaborative HIV Research, HIV experts and advocates mapped a pathway to reduce disparities in HIV/AIDS, applying the lessons learned from the Bay Area where disparities exist across the spectrum of care.

FEB-07-12  the Forum for Collaborative HIV Research has just released a new scientific paper that lays out a substantially different approach for conducting Phase 3 HIV clinical trials.  Click here to read more. 

OCT-18-11 As the world observes the 30th anniversary of HIV/AIDS, experts on the front lines in fighting the global pandemic are confronting a new and unexpected front in the war on this disease -the economic downturn, which has resulted in cuts to HIV prevention, care and treatment programs in the U.S. and poses a significant risk to HIV programs in resource-strained countries in the Caribbean, Africa, Eastern Europe and Central Asia.

SEP-20-11 The nation's war against HIV/AIDS began 30 years ago with reports that young homosexual men began to die from a new disease that was destroying their immune systems. But rather than simply observe this important milestone, the Forum for Collaborative HIV Research is using the 30^th anniversary of the AIDS epidemic to convene a major policy summit in Washington that will address the "unfinished business" of the HIV/AIDS research community - determining how to match the significant progress in drug discovery with the delivery of state-of-the-art care to every person infected or potentially infected with HIV.

AUG-24-11  To stem the estimated 2.6 million new HIV infections that occur worldwide each year, more than 200 representatives from the scientific and HIV/AIDS communities took an important step in assessing the safety and public health implications of providing antiretroviral drugs to uninfected men and women exposed to HIV through sexual contact - a strategy called pre-exposure prophylaxis, or PrEP.

MAR-30-11 Published in the March 29 issue of The Annals of the Forum for Collaborative HIV Research, Dr. Koop's paper -- The Early Days of AIDS, As I Remember Them -- is based on what the former Surgeon General described as his "last major address" on HIV/AIDS, which was presented in Washington on November 18, 2010 at the 2010 National Summit on HIV Diagnosis, Prevention and Access to Care. With a foreword from Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Koop's personal account chronicles the very real challenges facing the public health community at the beginning of the AIDS crisis and presents a candid assessment of how a small number of cases mushroomed into the AIDS epidemic of the late 1980s.

MAR-10-11 Building on more than a decade of identifying and addressing emerging issues in the prevention, care, and treatment of people affected by HIV/AIDS, Dr. Bartlett's appointment brings valuable expertise and new thinking to the Forum at a time when the organization is expanding its mission to advance the research agenda in TB/HIV co-infection and the HCV.